# Observational Study in Japanese Patients With Peripheral T-Cell Lymphoma Who Received Second-Line Therapy

> **NCT06422247** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 307 (actual)

## Conditions studied

- Peripheral T-cell Lymphoma

## Interventions

- **DRUG:** Systemic therapy

## Key facts

- **NCT ID:** NCT06422247
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-05
- **Primary completion:** 2025-02-05
- **Final completion:** 2025-02-05
- **Target enrollment:** 307 (ACTUAL)
- **Last updated:** 2025-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06422247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06422247, "Observational Study in Japanese Patients With Peripheral T-Cell Lymphoma Who Received Second-Line Therapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06422247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*